Once-weekly IcoSema versus multiple daily insulin injections in type 2 diabetes management (COMBINE 3): an open-label, multicentre, treat-to-target, non-inferiority, randomised, phase 3a trial

Journal:
The Lancet Diabetes & Endocrinology
Published:
DOI:
10.1016/s2213-8587(25)00052-x
Affiliations:
10
Authors:
10
Go to article
Institutions Authors Share
Novo Nordisk, Denmark
3.000000
 0.30
University of Magna Graecia (UMG), Italy
1.000000
 0.10
Peking University People's Hospital, PKUHSC, China
1.000000
 0.10
Tokyo Medical University, Japan
1.000000
 0.10
Chellaram Hospital, India
1.000000
 0.10
Hospital Nossa Senhora das Graças (HNSG), Brazil
1.000000
 0.10
Endeavor Health, United States of America (USA)
0.500000
 0.05
The University of Chicago (UChicago), United States of America (USA)
0.500000
 0.05
Toulouse University Hospital (CHU-Toulouse), France
0.500000
 0.05
Institute of Cardiovascular and Metabolic Diseases (I2MC), France
0.500000
 0.05
Interested in Clinical Sciences?